Rebekah Blankenship
About Rebekah Blankenship
Rebekah Blankenship serves as the Senior Accounting Manager at Mirati Therapeutics in San Diego, California, a position she has held since 2020. With a background in accounting and finance, she has accumulated extensive experience through various roles in different companies, including Vanda Pharmaceuticals and KPMG.
Work at Mirati Therapeutics
Rebekah Blankenship has been employed at Mirati Therapeutics since 2020, where she currently holds the position of Senior Accounting Manager. In this role, she oversees financial reporting and accounting operations within the organization. Prior to her current title, she served as Accounting Manager at Mirati Therapeutics from 2017 to 2020, contributing to the company's financial management during a critical growth period. Her work is based in San Diego, California.
Previous Experience in Accounting
Before joining Mirati Therapeutics, Rebekah Blankenship held several accounting roles. She worked as an Accounting Consultant at Argen Corporation for one year in 2016. Additionally, she served as a Consultant at Vanda Pharmaceuticals for 10 months in 2016 and briefly at Intuit for 2 months in the same year. Prior to these positions, she was the Senior Finance Manager at Vanda Pharmaceuticals from 2013 to 2016, where she managed financial operations in Washington, D.C. She also worked at KPMG as a Senior Federal Tax Associate from 2010 to 2013.
Education and Expertise
Rebekah Blankenship earned her Master of Accounting and Information Systems from Virginia Tech, completing the program from 2009 to 2010. She also holds a Bachelor of Science in Business with a focus on Accounting and Information Systems, which she obtained from the same institution between 2005 and 2009. Her educational background provides a strong foundation for her expertise in accounting and finance.
Career Timeline
Rebekah Blankenship's career in accounting spans over a decade, beginning with her education at Virginia Tech. After completing her bachelor's degree in 2009, she joined KPMG as a Senior Federal Tax Associate, where she worked until 2013. She then transitioned to Vanda Pharmaceuticals, where she served as Senior Finance Manager until 2016. Following her time at Vanda, she took on various consulting roles before joining Mirati Therapeutics in 2017.